Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Megan Eguchi"'
Publikováno v:
Aging and Cancer, Vol 3, Iss 2, Pp 105-115 (2022)
Abstract Background Bladder cancer is one of the top 10 cancers diagnosed in Americans with a median age of 73. This is the patient population that tends to be older with multiple medical conditions, and previously described variability in treatment
Externí odkaz:
https://doaj.org/article/a68e19d236f844029143462d1cdb1b04
Autor:
Jodi A. Kagihara, Elizabeth Molina, Lavanya Kondapalli, Peter Kabos, Jennifer R. Diamond, Cathy J. Bradley, Megan Eguchi, Elisabeth Meyer, Christine M. Fisher, Anna R Schreiber
Publikováno v:
Breast Cancer Research and Treatment
Purpose Adjuvant chemotherapy reduces recurrence in early-stage triple-negative breast cancer (TNBC). However, data are lacking evaluating anthracycline + taxane (ATAX) versus taxane-based (TAX) chemotherapy in older women with node-negative TNBC, as
Autor:
Daniel S. Han, Jonathan P. Walker, Andrew Nicklawsky, Peter Boxley, N. Valeska Halstead, Michael Tonzi, Sarah L. Hecht, Alyse Staley, Megan Eguchi, Myles G. Cockburn, Jonathan P. Roach, Amanda F. Saltzman, Nicholas G. Cost
Publikováno v:
The Journal of urology.
The majority of children with unilateral renal masses suspicious for malignancy undergo radical nephrectomy, while nephron-sparing surgery is reserved for select cases. We investigated the impact of tumor size on the probability of histology. We hypo
Lung Cancer Mortality Racial/Ethnic Disparities in Patient Experiences with Care: a SEER-CAHPS Study
Autor:
Albert J. Farias, Emily Chan, Stephanie Navarro, Elizabeth A. David, Megan Eguchi, Myles Cockburn
Publikováno v:
Journal of Racial and Ethnic Health Disparities.
To determine whether there are racial/ethnic disparities in patient experiences with care among lung cancer survivors, whether they are associated with mortality.A retrospective cohort study of lung cancer survivors 65 years old who completed a CAHPS
Autor:
Daniel S. Han, Jonathan P. Walker, Andrew Nicklawsky, Peter Boxley, N. Valeska Halstead, Michael Tonzi, Sarah L. Hecht, Alyse Staley, Megan Eguchi, Myles G. Cockburn, Jonathan P. Roach, Amanda F. Saltzman, Nicholas G. Cost
Publikováno v:
Journal of Urology. 209:590-590
Autor:
Jessica D. McDermott, Arya Amini, Megan Eguchi, Rustain Morgan, Julie A. Goddard, Evelinn A. Borrayo, Sana D. Karam
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:57-67
Background: In this population study, we compared head and neck cancer (HNC) prognosis and risk factors in 2 underserved minority groups (Hispanic and Black non-Hispanic patients) with those in other racial/ethnicity groups. Methods: In this SEER-Med
Autor:
Rustain Morgan, Adam C. Mueller, Megan Eguchi, Jessica D. McDermott, Julie A. Goddard, Arya Amini, Premal S. Trivedi, Sana D. Karam
Publikováno v:
Cancer. 127:535-543
Background Persistent controversy exists with regard to how and when patients with head and neck cancer should undergo imaging after definitive therapy. The current study was conducted to evaluate whether the type of imaging modality used in posttrea
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:856-865
Background: After discharge from an acute care hospitalization, patients with cancer may choose to pursue rehabilitative care in a skilled nursing facility (SNF). The objective of this study was to examine receipt of anticancer therapy, death, readmi
Autor:
Jared S. Johnson, Amanda F. Saltzman, Jonathan P. Walker, Myles Cockburn, Megan Eguchi, Nicholas G. Cost
Publikováno v:
J Pediatr Urol
Summary Background Lymph node (LN) involvement is an important prognostic indicator for patients with Wilms tumor (WT), and there have been previous reports of utilizing LN density (LND = positive LN/LNs examined) as an advanced metric to risk-strati
Publikováno v:
J Natl Cancer Inst
BackgroundAntineoplastic agents approved in recent decades are a marked advancement in cancer treatment, but they come at considerable cost. These drugs may widen survival disparities between patients who receive these agents and those who do not. We